SCHEMBL8648359

SCHEMBL8648359

NC(C=O)S(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
CA9 Q16790 1/20 0.55
F2 P00734 3/20 0.46
PRSS1 P07477 3/20 0.46
PRSS2 P07478 3/20 0.46
PRSS3 P35030 3/20 0.46
HTR6 P50406 2/20 0.46
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44
SLC1A1 P43005 1/20 0.44
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
AKR1B1 P15121 1/20 0.41
LOXL2 Q9Y4K0 2/20 0.40
SCN1A P35498 2/20 0.40
SCN2A Q99250 2/20 0.40
SCN3A Q9NY46 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27403973 0.79 CA1 (0.58) CA1CA2CA9F2PRSS1
SCHEMBL22068731 0.76 CA2 (0.60) CA2F2PRSS1PRSS2PRSS3
SCHEMBL4263471 0.76 CA2 (0.55) CA1CA2CA9F2PRSS1
SCHEMBL6572028 0.75 SLC1A3 (0.57) CA1CA2CA9F2PRSS1
SCHEMBL3245449 0.74 CA1 (0.57) CA1CA2CA9F2PRSS1
SCHEMBL9732748 0.74 CA1 (0.57) CA1CA2CA9F2PRSS1
SCHEMBL757927 0.74 CA1 (0.57) CA1CA2CA9F2PRSS1
SCHEMBL8954779 0.73 CA1 (0.51) CA1CA2CA9F2PRSS1
SCHEMBL9097795 0.73 CA1 (0.55) CA1CA2CA9F2PRSS1
SCHEMBL10880380 0.72 CA2 (0.64) CA1CA2CA9F2PRSS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0442843-B1 Inhibitors for the anticoagulant pretreatment of blood samples PENTAPHARM AG (CH) 1998-09-09 EP claimed
US-5187102-A Treating blood sample with thrombin inhibitor which does not bind bivalent cations PENTAPHARM AG (CH) 1993-02-16 US disclosed